AMLX
Amylyx Pharmaceuticals
$28.07
−$0.23 (−0.81%)Oct 28, 2026
Key metrics
The numbers that frame AMLX today
- Market cap
- $3.13B
- ROIC
- -133.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $10.83
- 52wk High
- $41.14
Growth
Revenue and earnings trend for AMLX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AMLX
Is Amylyx Pharmaceuticals a good buy?
Hold. Amylyx Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks strong, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Amylyx Pharmaceuticals is selling at a high price.
What is the market capitalization of AMLX?
Amylyx Pharmaceuticals's market capitalization is $3.13B.
What is the 52-week high for AMLX stock?
The 52-week high for Amylyx Pharmaceuticals is $41.14. The current close of $28.07 is 31.8% below that high.
What is the 52-week low for AMLX stock?
The 52-week low for Amylyx Pharmaceuticals is $10.83. The current close of $28.07 is 159.2% above that low.
Does AMLX stock pay dividends?
Amylyx Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AMLX?
Amylyx Pharmaceuticals's Debt / Equity ratio is 0.02.